Efficacy and Safety of Immunosuppression Withdrawal in Pediatric Liver Transplant Recipients: Moving Toward Personalized Management

Tolerance is transplantation’s holy grail, as it denotes allograft health without immunosuppression and its toxicities. Our aim was to determine, among stable long‐term pediatric liver transplant recipients, the efficacy and safety of immunosuppression withdrawal to identify operational tolerance.

[1]  A. Kirk,et al.  Immunosuppression Withdrawal in Liver Transplant Recipients on Sirolimus , 2019, Hepatology.

[2]  A. Demetris,et al.  IgG4 donor‐specific HLA antibody profile is associated with subclinical rejection in stable pediatric liver recipients , 2019, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[3]  A. Melk,et al.  High Burden of Subclinical Cardiovascular Target Organ Damage After Pediatric Liver Transplantation , 2019, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[4]  R. Wiesner,et al.  Not All Cellular Rejections Are the Same: Differences in Early and Late Hepatic Allograft Rejection , 2019, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[5]  S. Feng,et al.  Prevalence and Impact of De Novo Donor‐Specific Antibodies During a Multicenter Immunosuppression Withdrawal Trial in Adult Liver Transplant Recipients , 2019, Hepatology.

[6]  G. Klintmalm,et al.  Outcomes of immunosuppression minimization and withdrawal early after liver transplantation , 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[7]  A. Demetris,et al.  Evidence of Chronic Allograft Injury in Liver Biopsies From Long-term Pediatric Recipients of Liver Transplants. , 2018, Gastroenterology.

[8]  T. Karlsen,et al.  Cancer After Liver Transplantation in Children and Young Adults: A Population‐Based Study From 4 Nordic Countries , 2018, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[9]  M. Navasa,et al.  Molecular profiling of subclinical inflammatory lesions in long-term surviving adult liver transplant recipients. , 2018, Journal of hepatology.

[10]  P. André,et al.  Prevalence, Risk Factors, and Impact of Donor‐Specific Alloantibodies After Adult Liver Transplantation , 2018, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[11]  C. Guettier,et al.  Long‐term outcome of liver transplantation in childhood: A study of 20‐year survivors , 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[12]  B. Naini,et al.  Obliterative portal venopathy: A histopathologic finding associated with chronic antibody‐mediated rejection in pediatric liver allografts , 2018, Pediatric transplantation.

[13]  S. Feng,et al.  Tolerance after liver transplantation: Where are we? , 2017, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[14]  S. Feng,et al.  Tolerance in clinical liver transplantation. , 2017, Human immunology.

[15]  M. Abecassis,et al.  Acute Rejection Increases Risk of Graft Failure and Death in Recent Liver Transplant Recipients , 2017, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[16]  P. Rosenthal,et al.  Five‐year histological and serological follow‐up of operationally tolerant pediatric liver transplant recipients enrolled in WISP‐R , 2017, Hepatology.

[17]  N. Kamar,et al.  Donor-specific antibodies and liver transplantation. , 2016, Human immunology.

[18]  E. Furth,et al.  2016 Comprehensive Update of the Banff Working Group on Liver Allograft Pathology: Introduction of Antibody‐Mediated Rejection , 2016, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[19]  E. Fadel,et al.  De-novo donor-specific anti-HLA antibodies 30 days after lung transplantation are associated with a worse outcome. , 2016, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[20]  S. Todo,et al.  A pilot study of operational tolerance with a regulatory T‐cell‐based cell therapy in living donor liver transplantation , 2016, Hepatology.

[21]  A. Sánchez‐Fueyo,et al.  Hepatic Infiltrates in Operational Tolerant Patients After Liver Transplantation Show Enrichment of Regulatory T Cells Before Proinflammatory Genes Are Downregulated , 2016, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[22]  J. Lozano,et al.  Molecular Characterization of Acute Cellular Rejection Occurring During Intentional Immunosuppression Withdrawal in Liver Transplantation , 2016, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[23]  P. Nickerson,et al.  Rates and Determinants of Progression to Graft Failure in Kidney Allograft Recipients With De Novo Donor‐Specific Antibody , 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[24]  Y. Wong,et al.  Immune outcomes in the liver: Is CD8 T cell fate determined by the environment? , 2015, Journal of hepatology.

[25]  E. Reed,et al.  Donor-specific HLA Antibodies Are Associated With Late Allograft Dysfunction After Pediatric Liver Transplantation , 2015, Transplantation.

[26]  F. Ginhoux,et al.  Liver inflammation abrogates immunological tolerance induced by Kupffer cells , 2015, Hepatology.

[27]  P. Nickerson,et al.  Adverse Outcomes of Tacrolimus Withdrawal in Immune-Quiescent Kidney Transplant Recipients. , 2015, Journal of the American Society of Nephrology : JASN.

[28]  I. N. Crispe,et al.  Immune tolerance in liver disease , 2014, Hepatology.

[29]  G. Klintmalm,et al.  The Role of Donor‐Specific HLA Alloantibodies in Liver Transplantation , 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[30]  D. Roelen,et al.  Prospective multicenter clinical trial of immunosuppressive drug withdrawal in stable adult liver transplant recipients , 2013, Hepatology.

[31]  P. Reese,et al.  End-Stage Kidney Disease After Pediatric Nonrenal Solid Organ Transplantation , 2013, Pediatrics.

[32]  J. Neuberger,et al.  Late Acute Liver Allograft Rejection; A Study of Its Natural History and Graft Survival in the Current Era , 2013, Transplantation.

[33]  C. Sempoux,et al.  Novel Histologic Scoring System for Long‐Term Allograft Fibrosis After Liver Transplantation in Children , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[34]  S. Uemoto,et al.  Progressive graft fibrosis and donor‐specific human leukocyte antigen antibodies in pediatric late liver allografts , 2012, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[35]  C. Bellamy.  Importance of liver biopsy findings in immunosuppression management: biopsy monitoring and working criteria for patients with operational tolerance. , 2012, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[36]  M. Stegall,et al.  Prevalence, Course and Impact of HLA Donor‐Specific Antibodies in Liver Transplantation in the First Year , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[37]  J. Varni,et al.  Health status of children alive 10 years after pediatric liver transplantation performed in the US and Canada: report of the studies of pediatric liver transplantation experience. , 2012, The Journal of pediatrics.

[38]  N. Banner,et al.  Late Antibody-Mediated Rejection After Heart Transplantation Following the Development of De Novo Donor-Specific Human Leukocyte Antigen Antibody , 2012, Transplantation.

[39]  P. Rosenthal,et al.  Complete immunosuppression withdrawal and subsequent allograft function among pediatric recipients of parental living donor liver transplants. , 2012, JAMA.

[40]  D. Swinkels,et al.  Intra-graft expression of genes involved in iron homeostasis predicts the development of operational tolerance in human liver transplantation. , 2012, The Journal of clinical investigation.

[41]  H. Verkade,et al.  Graft fibrosis after pediatric liver transplantation: Ten years of follow‐up , 2009, Hepatology.

[42]  Y. Li,et al.  The Presence of Foxp3 Expressing T Cells Within Grafts of Tolerant Human Liver Transplant Recipients , 2008, Transplantation.

[43]  R. Seshadri,et al.  Graft histology characteristics in long‐term survivors of pediatric liver transplantation , 2008, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[44]  Steven R. Martin,et al.  Interface hepatitis is associated with a high incidence of late graft fibrosis in a group of tightly monitored pediatric orthotopic liver transplantation patients , 2008, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[45]  G. Klintmalm,et al.  Late acute rejection after liver transplantation impacts patient survival , 2008, Clinical transplantation.

[46]  A. M. Shapiro,et al.  High Risk of Sensitization After Failed Islet Transplantation , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[47]  G. Mazariegos,et al.  Late Graft Loss or Death in Pediatric Liver Transplantation: An Analysis of the SPLIT Database , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[48]  S. Hübscher,et al.  Progressive histological damage in liver allografts following pediatric liver transplantation , 2006, Hepatology.

[49]  B. Portmann,et al.  Tolerance and latent cellular rejection in long‐term liver transplant recipients , 1998, Hepatology.